Recruiting

Observational Study

Sponsor:

Cedars-Sinai Medical Center

Code:

NCT00599092

Conditions

Pituitary Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.

Conditions

Pituitary Tumor

Study ID

NCT00599092

Start date

Jan, 1997

Status verified date

Mar, 2026

Completion date

Dec, 2050

Anticipated

Primary completion date

Dec, 2050

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • patients with confirmed pituitary disease

Exclusion Criteria:

  • patients who do not have confirmed pituitary disease

Study Design

Enrollment

1250 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Overall Survival (Longevity) [ Time Frame: 20 years ]

Central Contacts and Locations

Locations

Cedars-Sinai Medical Center, Pituitary Center

Recruiting

Los Angeles, California, United States, 90048

Contacts

Daniel Gomez

424-315-2362daniel.gomez@cshs.org

Principal Investigator:

Shlomo Melmed, MD

More Information

Sponsor

Cedars-Sinai Medical Center

Last update posted

Mar 23, 2026

Last verified

Mar, 2026

Keywords

  • pituitary tumor
  • recurrence

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Cedars-Sinai Medical Center on 2026-03-23.